Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |